The Keratoconus market will be dominated by lenses, cross-linking procedures as well as IVMED-80, if approved in the coming decade.
Keratoconus, away from the general perception of a rare disease, has come a long way. Thirty-four years back, in Minnesota, United States, this disease was claimed as rare, which created a gap in disease understanding; however, this disparity has evolved dramatically with time. Since the 90s, the advancement in diagnostic tools such as corneal topography has soared the diagnosis rate at a commendable rate. The improvement, recognition, and research progress has made the disease well-known. Moreover, DelveInsight estimates the number ...
